A new study has found that one in three early-stage breast cancer patients who received genomic testing when deciding about treatment options felt they did not fully understand their discussions with physicians about their test results and their risk of recurrence.
Read »Navigation
User login
Visit the BiotechMashup Blog
Best upcoming scoops - Health
- New ways sleep-wake patterns are like clockwork
- Unsafe at any speed: Even for driving pros, distractions increase crash risk
- Fever during pregnancy more than doubles the risk of autism or developmental delay
- Scientists unravel role of fusion gene in prostate cancer
- Food fight or romantic dinner? Communication between couples is key to improving men's diets